RTI-160

Edit links
Source: Wikipedia, the free encyclopedia.
RTI-160
Identifiers
  • [(2R,3S)-2-(Dimethylcarbamoyl)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] benzoate
JSmol)
  • CN1C2CCC1[C@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)N(C)C
  • InChI=1S/C18H24N2O3/c1-19(2)17(21)16-14-10-9-13(20(14)3)11-15(16)23-18(22)12-7-5-4-6-8-12/h4-8,13-16H,9-11H2,1-3H3/t13?,14?,15-,16+/m0/s1
  • Key:KCJKRDUKFUVPDP-SSHXOBKSSA-N

RTI-160 (benzoylecgonine dimethylamide) is a tropane derivative drug with stimulant effects, having similar potency as a dopamine reuptake inhibitor to cocaine. It is synthesized by an amide condensation reaction between benzoylecgonine and dimethylamine.[1][2]

See also

References

  1. PMID 7830281
    .
  2. PMID 14695827
    .
Retrieved from "https://en.wikipedia.org/w/index.php?title=RTI-160&oldid=1211885400"